BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+27.77%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.73B
AUM Growth
+$8.73B
(+21%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
234
New
17
Increased
81
Reduced
66
Closed
12
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 3 |
Mersana Therapeutics
MRSN
|
$51.3M |
| 4 |
Arvinas
ARVN
|
$46.7M |
| 5 |
AbbVie
ABBV
|
$36.3M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$154M |
| 2 |
Halozyme
HALO
|
$60.8M |
| 3 |
Pacific Biosciences
PACB
|
$57.2M |
| 4 |
CareDx
CDNA
|
$55.9M |
| 5 |
Charles River Laboratories
CRL
|
$52M |
Sector Composition
| 1 | Healthcare | 95.9% |
| 2 | Technology | 0.6% |
| 3 | Industrials | 0.33% |
| 4 | Financials | 0.11% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Beam Therapeutics
BEAM
$1.9B
| $32.4M | 0.37% |
+396,821
| New | +$32.4M |
|
77
AtriCure
ATRC
$1.73B
| $31M | 0.35% |
+556,374
| New | +$31M |
|
78
Veeva Systems
VEEV
$44.4B
| $30.5M | 0.35% |
111,941
+16,574
| +17% | +$4.51M |
|
79
HUTCHMED
HCM
$2.62B
| $30.3M | 0.35% |
947,674
| – | – |
|
80
NeoGenomics
NEO
$1.06B
| $29.5M | 0.34% |
548,446
+121,554
| +28% | +$6.54M |
|
81
Masimo
MASI
$7.43B
| $28.9M | 0.33% |
107,824
+5,671
| +6% | +$1.52M |
|
|
ONEM
82
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $27.8M | 0.32% |
637,553
+168,989
| +36% | +$7.38M |
|
|
HZNP
83
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $27.8M | 0.32% |
380,200
+302,800
| +391% | +$22.2M |
|
|
ONC
84
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $27.7M | 0.32% |
107,100
+67,700
| +172% | +$17.5M |
|
85
Health Catalyst
HCAT
$228M
| $27M | 0.31% |
620,210
+98,314
| +19% | +$4.28M |
|
86
Exact Sciences
EXAS
$9.33B
| $25.8M | 0.3% |
195,000
-109,490
| -36% | -$14.5M |
|
87
Penumbra
PEN
$10.5B
| $25.8M | 0.3% |
147,495
+26,301
| +22% | +$4.6M |
|
88
Phreesia
PHR
$1.81B
| $25.7M | 0.29% |
472,720
+45,764
| +11% | +$2.48M |
|
|
89
CareDx
CDNA
$678M
| $24.9M | 0.29% |
343,983
-771,920
| -69% | -$55.9M |
|
90
American Well
AMWL
$112M
| $23.9M | 0.27% |
942,154
+562,300
| +148% | +$14.2M |
|
91
Kezar Life Sciences
KZR
$28.5M
| $23.7M | 0.27% |
4,533,148
| – | – |
|
|
SILK
92
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $23.5M | 0.27% |
372,890
+72,271
| +24% | +$4.55M |
|
93
iRhythm Technologies
IRTC
$5.67B
| $23.4M | 0.27% |
98,602
+8,084
| +9% | +$1.92M |
|
94
10x Genomics
TXG
$1.66B
| $23.4M | 0.27% |
165,123
+11,134
| +7% | +$1.58M |
|
95
Guardant Health
GH
$8.11B
| $23.1M | 0.26% |
179,241
+16,858
| +10% | +$2.17M |
|
|
NVRO
96
DELISTED
NEVRO CORP.
NVRO
| $22.6M | 0.26% |
130,402
+9,833
| +8% | +$1.7M |
|
97
ResMed
RMD
$39.4B
| $21M | 0.24% |
98,975
+21,170
| +27% | +$4.5M |
|
|
AMED
98
DELISTED
Amedisys
AMED
| $20.9M | 0.24% |
71,190
+9,339
| +15% | +$2.74M |
|
99
Thermo Fisher Scientific
TMO
$183B
| $20.7M | 0.24% |
44,455
-26,410
| -37% | -$12.3M |
|
100
Wave Life Sciences
WVE
$1.27B
| $20.5M | 0.23% |
2,602,858
| – | – |
|